Sage Journals: Discover world-class research

Retricted access

Research article

First published 2021-12

Understanding Constraints and Enablers of Turnaround Time for Ethics Review: The Case of Institutional Review Boards in Tanzania

Mwifadhi Mrisho, Zaynab Essack

Journal of Empirical Research on Human Research Ethics

Free access

Research article

First published 2009-05

Research governance delays for a multicentre non-interventional study

Andrew A Mallick, Finbar JK O'Callaghan

Journal of the Royal Society of Medicine

Retricted access

Research article

First published 1995-1

The Timeliness of New Drug Approvals in Canada: A Rejoinder

Joel Lexchin

International Journal of Social Determinants of Health and Health Services

Retricted access

Research article

First published 1994-1

Regulatory Strategy: A Blueprint for Drug Development

Loren L. Miller, Patricia P. Edgar, Vivian Lackey [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2016-2

Reduced Survival in Bariatric Surgery Candidates Delayed or Denied by Lack of Insurance Approval

Eleisha Flanagan, Iman Ghaderi, D. Wayne Overby [...]

The American Surgeon™

Open access

Research article

First published 2025

An Empirical Analysis of Anti-Cancer Drug Lags in South Korea

Sung Kyung Lee, Jong Hyuk Lee

INQUIRY: The Journal of Health Care Organization,Provision,and Financing

Retricted access

Research article

First published 2021-7

Facilitating Timely Institutional Review Board Review: Common Issues and Recommendations

Emily Rodriguez, Challace Pahlevan-lbrekic, Elaine L. Larson

Journal of Empirical Research on Human Research Ethics

Retricted access

Research article

First published 2024-12

Evaluation of delays in technical approval of UK Highways Act Section 278 projects

Meghdad Bagheri, Edward Bate

International Journal of Commerce and Contracting

Retricted access

Research article

First published 2023-11

Sequential versus concurrent final phase product development: Approval uncertainty,time‐sensitive consumers,asymmetric competition,and government subsidy

Yasemin Limon, Christopher S. Tang, Fehmi Tanrısever

Production and Operations Management

Retricted access

Other

First published 1993-10

Risk/Benefit Assessment: The “Greased Pig” of Drug Development

Loren L. Miller

Therapeutic Innovation & Regulatory Science

Search results